A critical assessment of the synthesis and biological activity of p53/human double minute 2‐stapled peptide inhibitors
暂无分享,去创建一个
T. Vorherr | P. Chène | S. Ruetz | R. Brock | T. Stachyra | R. Wallbrecher
[1] D. Neuberg,et al. Biophysical Determinants for Cellular Uptake of Hydrocarbon-Stapled Peptide Helices , 2016, Nature chemical biology.
[2] L. Walensky,et al. Cellular Uptake and Ultrastructural Localization Underlie the Pro-apoptotic Activity of a Hydrocarbon-stapled BIM BH3 Peptide. , 2015, ACS chemical biology.
[3] Paul A Insel,et al. Experimental design and analysis and their reporting: new guidance for publication in BJP , 2015, British journal of pharmacology.
[4] T. Vorherr. Modifying peptides to enhance permeability. , 2015, Future medicinal chemistry.
[5] W. Sellers,et al. A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097 , 2015, eLife.
[6] G. Verdine,et al. Towards understanding cell penetration by stapled peptides , 2015 .
[7] Lei Wang,et al. A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time. , 2014, Cell reports.
[8] Hong-Gang Wang,et al. Synthesis of cell-permeable stapled BH3 peptide-based Mcl-1 inhibitors containing simple aryl and vinylaryl cross-linkers. , 2014, Tetrahedron.
[9] R. Brock,et al. Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. , 2014, Bioconjugate chemistry.
[10] R. Brock. The uptake of arginine-rich cell-penetrating peptides: putting the puzzle together. , 2014, Bioconjugate chemistry.
[11] Ü. Langel,et al. Cell-penetrating peptides: design, synthesis, and applications. , 2014, ACS nano.
[12] L. Walensky,et al. Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress , 2014, Journal of medicinal chemistry.
[13] L. Vassilev,et al. Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy , 2013, Proceedings of the National Academy of Sciences.
[14] D. Lane,et al. Stapled peptides with improved potency and specificity that activate p53. , 2013, ACS chemical biology.
[15] Andrew J. Wilson,et al. Inhibition of α-helix-mediated protein-protein interactions using designed molecules. , 2013, Nature chemistry.
[16] F. Milletti,et al. Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.
[17] A. Metspalu,et al. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo , 2011, Nucleic acids research.
[18] E. Gulbins,et al. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[19] G. Verdine,et al. Stereochemical effects of all-hydrocarbon tethers in i,i+4 stapled peptides. , 2009, Bioorganic & medicinal chemistry letters.
[20] S. Futaki,et al. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. , 2008, Bioconjugate chemistry.
[21] Rainer Fischer,et al. A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides , 2007, Traffic.
[22] Christoph Patsch,et al. The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .
[23] S. Korsmeyer,et al. Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.
[24] Steven F Dowdy,et al. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.
[25] G. Verdine,et al. An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .